>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:

  • GDOT -42.2%, ICUI -29.2%, RYAM -28%, TRXC -27%, ANGI -26.3%, CWH -26%, AGS -24.9%, WMGI -20.9%, DDD -15.3%, DVAX -14.4%, ZG -14.2%, IAG -13.2% (also announces initial drilling results testing the underground mining potential at its Saramacca Project, Suriname), PRTY -12.1%, FLO -9.2%, GRVY -8.6%, CAAS -8%, BREW -7.8%, RUN -7.7%, MNST -7.3%, GKOS -7%, TPIC -4.9%, LEE -4.9%, SWKS -4.5%, SRPT -3.9%, EBIX -3.9%, FOSL -3.8%, SENS -3.7%, QHC -3.4%, QRTEA -3.2%, RWLK -3.2%, COMM -3.1%, CTL -2.9%, TRIP -2.8%, IMMU -2.8%, EXK -2.7%, PAAS -2.5%, KHC -2.5%, ARNA -2.3%, TCRR -2%, CDE -1.9%, LBTYA -1.9%, UHAL -1.7%, EB -1.6%, SWCH -1.5%, GFI -1.5%, VRS -1.5%, NCLH -1.4%, SPH -1.3%, SUN -1.2%, VSTO -1.2%, ESPR -1.2%

M&A news:

  • GKOS -7% (to acquire Avedro [AVDR] in an all-stock transaction

Other news:

  • DVAX -14.4% (to offer an aggregate of up to $60.0 million of shares of its common stock)
  • CLVS -10.8% (to offer $225 million aggregate principal amount of its convertible senior notes due 2024 in a private placement to qualified institutional buyers )
  • MGTX -8.1% (prices underwritten public offering of 3.2 mln of its ordinary shares at a public offering price of $23.50 per share)
  • STML -8% (announces 5,000,000 shares of its common stock in an underwritten public offering)
  • BL -3.2% (to offer $435 mln aggregate principal amount of convertible senior notes due 2024 in a private placement to qualified institutional buyers )
  • MLAB -3.2% (prices offering of 375K shares of common stock at $210.00 per share)
  • SAFE -2.5% (prices offering of 3 mln shares of common stock for $84 mln)
  • EYE -1.5% (prices underwritten secondary offering by KKR (KKR) of 9,149,908 shares of common stock at the public offering price of $31.00 per share)
  • KNSL -1.4% (prices offering of 645,000 shares of common stock at $93.00 per share)
  • WAB -0.9% (announced the pricing of 20,485,156 share offering at a public offering price of $72.50 by General Electric (GE) as the sole selling stockholder)
  • PTCT -0.9% (discloses entry into $125 mln at the market offering sales agreement)

Analyst comments:

  • CDXC -2.1% (receives positive opinion on Nicotinamide Riboside as a novel food ingredient from the EFSA)
  • MTCH -1.5% (downgraded to Neutral from Buy at UBS)
  • CAT -1.3% (downgraded to Neutral from Buy at Goldman)